Skip to main content
# Title Department Research Year
61 Ruthenium nanoparticles encrusted with nitrogen & sulphur magnetic quantum dots as an efficient electrochemical sensor for simultaneous determination of itraconazole and terbinafine; a dual regimen for black fungus: Magnetic solid phase micro-extractio 2024
62 Fabrication and optimization of naringin-loaded MOF-5 encapsulated by liponiosomes as smart drug delivery, cytotoxicity, and apoptotic on breast cancer cells Department of Industrial Pharmacy 2024
63 Innovating uric acid Biosensing: Development of a GSH@Cd-Mediated Dual-Signal fluorometric method Department of Pharmaceutical Analytical Chemistry 2024
64 Hybrids of 4-aminosalicylic acid with dual anti-mycobacterial and anti-inflammatory activities: Synthesis, biological evaluation, in silico investigation and structure-activity relationships exploration Department of Pharmaceutical Organic Chemistry 2024
65 Phytochemical Screening and chemical investigation of lipoidal matter of the leaves of Latania verschaffeltii Lem. Family Arecaceae cultivated in Egypt Department of Pharmacognosy 2024
66 Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions Department of Pharmaceutical Organic Chemistry 2024
67 Design and preparation of a fluorescent molecularly imprinted membrane for the selective detection of pepsin enzyme as a biomarker for gastroesophageal reflux disease. Department of Pharmaceutical Analytical Chemistry 2024
68 A novel urease-assisted ratiometric fluorescence sensing platform based on pH-modulated copper-quenched near-infrared carbon dots and methyl red-quenched red carbon dots for Department of Pharmaceutical Analytical Chemistry 2024
69 Synergistic effects of quercetin-loaded CoFe2O4@Liposomes regulate DNA damage and apoptosis in MCF-7 cancer cells: based on biophysical magnetic hyperthermia Department of Industrial Pharmacy 2024
70 Rosuvastatin Flexible Chitosomes: Development, In Vitro Evaluation and Enhancement of Anticancer Efficacy Against HepG2 and MCF7 Cell Lines Department of Pharmaceutics 2024